Binh Nguyen Wynngate Corp.
Binh Nguyen Wynngate Corp. President
Dr. Binh Nguyen retired from the FDA in March 2024 after 20 years of specializing in pharmaceutical training, compliance, and inspectional audits for CDER (Center for Drug Evaluation and Research) and ORA (Office of Regulatory Affairs). After retirement, he founded the Wynngate Corporation, a bio/pharmaceutical consulting firm, and developed ieQip, an AI-powered inspection software for audits. As a Level III Certified Pharmaceutical Inspectorate and a Level II Drug Auditor, Dr. Nguyen held key roles, including Drug Branch Chief and Director Regulatory Review Officer for biotech, sterile injectables, sterile compounding, positron emission tomography, combination products, and other dosage forms. He was a clinical & compounding pharmacist at UCI Hospital for 21 years, served as a counsel member in sterile compounding pharmacy for the Board of Pharmacy Specialties for 3 years. Dr. Nguyen earned a Doctorate in pharmacy & a Master’s in regulatory science from the University of Southern California.